The US Supreme Court has overturned two methods patents on drug dose calibration held by biotech company Prometheus Laboratories, reports The Scientist's Sabrina Richards. The company's patents concerned the calibration of synthetic thiopurines, which are used to treat auto-immune diseases like Crohn's disease, Richards says. "Prometheus's methods rely on monitoring the levels of various metabolites in red blood cells," she adds.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.